Synchronization of Nanoparticle Sensitization and Radiosensitizing Chemotherapy through Cell Cycle Arrest Achieving Ultralow X-ray Dose Delivery to Pancreatic Tumors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synchronization of Nanoparticle Sensitization and Radiosensitizing Chemotherapy through Cell Cycle Arrest Achieving Ultralow X-ray Dose Delivery to Pancreatic Tumors
Authors
Keywords
-
Journal
ACS Nano
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2021-05-12
DOI
10.1021/acsnano.1c02283
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications
- (2020) Francis Boateng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chemical Mechanisms of Nanoparticle Radiosensitization and Radioprotection: A Review of Structure-Function Relationships Influencing Reactive Oxygen Species
- (2020) Douglas Howard et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges
- (2020) Jing Jin et al. JOURNAL OF NANOBIOTECHNOLOGY
- Folate receptors and transporters: biological role and diagnostic/therapeutic targets in cancer and other diseases
- (2019) Barbara Frigerio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Redox-Responsive and Dual-Targeting Hyaluronic Acid–Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery
- (2019) Yubin Zhang et al. MOLECULAR PHARMACEUTICS
- Therapeutic developments in pancreatic cancer: current and future perspectives
- (2018) John P. Neoptolemos et al. Nature Reviews Gastroenterology & Hepatology
- Advances in targeting the folate receptor in the treatment/imaging of cancers
- (2018) Marcos Fernández et al. Chemical Science
- Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2017) Alok A. Khorana et al. JOURNAL OF CLINICAL ONCOLOGY
- Chitosan promotes ROS-mediated apoptosis and S phase cell cycle arrest in triple-negative breast cancer cells: evidence for intercalative interaction with genomic DNA
- (2017) Fahimeh Salehi et al. RSC Advances
- Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer
- (2016) Steffi J. Rombouts et al. ANNALS OF SURGICAL ONCOLOGY
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer
- (2016) Pavan P. Adiseshaiah et al. Nature Reviews Clinical Oncology
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience
- (2015) Ulrich Nitsche et al. ANNALS OF SURGICAL ONCOLOGY
- Mechanisms and Implications of Dual-Acting Methotrexate in Folate-Targeted Nanotherapeutic Delivery
- (2015) Pamela Wong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Expanded analyses of napoli-1: Phase 3 study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin, versus 5-fluorouracil and leucovorin, in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy.
- (2015) Li-Tzong Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- Green synthesis of bacterial mediated anti-proliferative gold nanoparticles: inducing mitotic arrest (G2/M phase) and apoptosis (intrinsic pathway)
- (2015) C. Ganesh Kumar et al. Nanoscale
- FOLFIRINOX-Based Neoadjuvant Therapy in Borderline Resectable or Unresectable Pancreatic Cancer
- (2015) Fausto Petrelli et al. PANCREAS
- Marriage of Scintillator and Semiconductor for Synchronous Radiotherapy and Deep Photodynamic Therapy with Diminished Oxygen Dependence
- (2014) Chen Zhang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Gold nanoparticles and their alternatives for radiation therapy enhancement
- (2014) Daniel R. Cooper et al. Frontiers in Chemistry
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells
- (2012) Anne-Laure Papa et al. BMC CANCER
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Synthesis of In2O3@SiO2Core–Shell Nanoparticles with Enhanced Deeper Energy Level Emissions of In2O3
- (2011) Yiping Fang et al. LANGMUIR
- Genexol inhibits primary tumour growth and metastases in gemcitabine-resistant pancreatic ductal adenocarcinoma
- (2011) Jill E. Shea et al. HPB
- Methotrexate, Paclitaxel, and Doxorubicin Radiosensitize HER2-Amplified Human Breast Cancer Cells to the Auger Electron-Emitting Radiotherapeutic Agent 111In-NLS-Trastuzumab
- (2010) D. L. Costantini et al. JOURNAL OF NUCLEAR MEDICINE
- Enhancement of radiation effect by heavy elements
- (2010) K. Kobayashi et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Photocleavage of the Polypeptide Backbone by 2-Nitrophenylalanine
- (2009) Francis B. Peters et al. CHEMISTRY & BIOLOGY
- Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle
- (2009) Wilson Roa et al. NANOTECHNOLOGY
- Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer
- (2008) Petras Juzenas et al. ADVANCED DRUG DELIVERY REVIEWS
- Multicolor Core/Shell-Structured Upconversion Fluorescent Nanoparticles
- (2008) Zhengquan Li et al. ADVANCED MATERIALS
- Trastuzumab-Resistant Breast Cancer Cells Remain Sensitive to the Auger Electron-Emitting Radiotherapeutic Agent 111In-NLS-Trastuzumab and Are Radiosensitized by Methotrexate
- (2008) D. L. Costantini et al. JOURNAL OF NUCLEAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started